<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="use compulsory license Oseltamivir phosphate Taiwan Compulsory license CD-R and" exact="oseltamivir" post="phosphate Brazil In 2005, Brazil began negotiations to issue"/>
 <result pre="of those receiving ARV treatment in Brazil will be using" exact="efavirenz" post="by the end of 2007. Efavirenz (in tablets of"/>
 <result pre="threatened Merck with a compulsory license unless Brazil could sell" exact="efavirenz" post="at a rate equal to or less than the"/>
 <result pre="[18, 19], the Thai government issued a compulsory license for" exact="efavirenz" post="on December 6, 2006, and began the local production"/>
 <result pre="nationwide anthrax scare in USA resulting in rising demands for" exact="ciprofloxacin" post="(Cipro). Anecdotally, many health professionals believe that &quot;it is"/>
 <result pre="cost of the ARV drugs. For instance, the price of" exact="lamivudine" post="(3TC) could be reduced to one-tenth of the current"/>
 <result pre="reduced to one-tenth of the current price in China and" exact="nevirapine" post="to one-tenth of its international price. Trizivir would only"/>
</results>
